News and Events

IDEXX Laboratories Announces Fourth Quarter and Full Year Results
WESTBROOK, Maine, January 27, 2012—IDEXX Laboratories, Inc. (NASDAQ: IDXX), today reported that revenues for the fourth quarter of 2011 increased 8% to $307.2 million, from $283.8 million for the fourth quarter of 2010. Organic revenue growth, as defined below, was 7%. Earnings per diluted share ("EPS") for the quarter ended December 31, 2011 increased 8% to $0.67, compared to $0.62 for the same period in the prior year. Fourth quarter 2011 EPS includes a $3 million milestone payment earned related to the 2008 sale of product rights previously included in our pharmaceutical product line, which added $0.03 to EPS. Fourth quarter 2010 EPS of $0.62 included a similar milestone payment as well as the full year 2010 benefit from the reinstatement of the Federal Research and Development tax credit, which added a combined $0.06 to EPS.

IDEXX Laboratories to Release 2011 Fourth Quarter and Full-Year Financial Results
WESTBROOK, Maine, January 18, 2012—IDEXX Laboratories, Inc. (Nasdaq: IDXX), has scheduled the release of its 2011 fourth quarter and full-year financial results for Friday, January 27, at approximately 7:00 a.m. (eastern). The Company will conduct an analyst conference call beginning at 9:00 a.m. (eastern) on that day.

IDEXX Announces Real-Time Care™ Work-Flow Consultations
WESTBROOK, Maine, January 11, 2012—Laboratories, Inc. announces the launch of IDEXX Real-Time Care™ work-flow consultations for veterinary clinics that wish to provide better patient care and an enhanced customer experience through a more efficient work flow. Trained consultants provide feedback and suggest processes to help streamline the clinic work flow in ways that positively affect all areas, from patient care to client value and profitability. Practices across the country that participated in the pilot program have already seen measurable improvement.

IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference
WESTBROOK, Maine, January 03, 2012—IDEXX Laboratories, Inc. (NASDAQ: IDXX), announced today that it will participate in the 30th Annual J.P. Morgan Healthcare Conference. Jonathan W. Ayers, Chairman and CEO, is scheduled to make a presentation on the Company on Monday, January 9, 2012 at 2:30 p.m. (PT), at the Westin St. Francis Hotel, San Francisco, California. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archived edition of the presentation will be available for 14 days via the same link.